Matt Amberson presents ORATS new backtesting capabilities and case studies at the Benzinga Fintech Conference. See the presentation HERE.
Celgene (CELG) is to be bought by Bristol-Myers Squibb (BMY) at a 54% premium to the closing...
Listen to the latest episode of The Advisor's Option, by Mark Longo of the Option Insider,...
Still curious how we can help you?
1608 S. Ashland Ave. #98141
Chicago, IL 60608
36 Maplewood Ave.
Portsmouth, NH 03801